JESSICA J SLABA
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner SIOUX FALLS, SD NPI 1770190993
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner SD E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$4,134.01
- Category: General Payments
- Program years: PY2022–2024
- Record count: 43
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,032.03 across 37 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,622.00 | 3 |
| Food and Beverage | $745.55 | 30 |
| Travel and Lodging | $364.48 | 3 |
| Consulting Fee | $300.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,171.67 | 9 |
| Celgene Corporation | $375.08 | 5 |
| ABBVIE INC. | $83.61 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $79.29 | 4 |
| Legend Biotech USA Inc. | $50.93 | 2 |
| BeiGene USA, Inc. | $43.80 | 2 |
| Rigel Pharmaceuticals, Inc. | $39.47 | 2 |
| Daiichi Sankyo Inc. | $35.02 | 2 |
| Genmab U.S., Inc. | $26.20 | 1 |
| Incyte Corporation | $24.39 | 1 |
| ADC Therapeutics America, Inc. | $20.25 | 1 |
| PharmaEssentia USA Corporation | $19.04 | 1 |
| Genentech USA, Inc. | $18.22 | 1 |
| Astellas Pharma US Inc | $17.06 | 1 |
| Acerta Pharma LLC | $14.84 | 1 |
| Janssen Biotech, Inc. | $13.16 | 1 |
By program year
Records — PY2024 (37)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.